Gynecomastia in Patients with Prostate Cancer: A Systematic Review.

Anders Fagerlund, Luigi Cormio, Lina Palangi, Richard Lewin, Fabio Santanelli di Pompeo, Anna Elander, Gennaro Selvaggi

May 2016

Synopsis of Social media discussions

The posts show recognition of the review's significance, with statements like 'tamoxifen and radiotherapy are effective options,' and references to how managing gynecomastia can improve patient quality of life. The tone remains thoughtful and informative, emphasizing the review's relevance to treatment strategies and patient outcomes.

A
Agreement
 Moderate agreement

Most discussions agree with the publication, acknowledging its findings on gynecomastia as a common side effect and the effectiveness of treatments like tamoxifen and radiotherapy.

I
Interest
 Moderate level of interest

Users demonstrate moderate interest, discussing the implications for patient quality of life and treatment options without overwhelming technical detail.

E
Engagement
 Moderate level of engagement

Participants engage by referencing specific aspects of the review, such as treatment efficacy and side effects, indicating a genuine interest in understanding and applying the information.

I
Impact
 Moderate level of impact

The discourse suggests the publication could influence clinical practices and patient care, as users highlight the importance of managing gynecomastia in prostate cancer treatments.

Social Mentions

YouTube

2 Videos

Twitter

1 Posts

Reddit

2 Posts

Metrics

Video Views

885

Total Likes

10

Extended Reach

2,712

Social Features

5

Timeline: Posts about article

Top Social Media Posts

Posts referencing the article

Understanding CYP 17 Inhibitors and Androgen Synthesis in Prostate Cancer

Understanding CYP 17 Inhibitors and Androgen Synthesis in Prostate Cancer

This video provides insights into hormone therapy for prostate cancer, including the mechanisms of androgen synthesis and action, and the role of CYP 17 inhibitors like Abiraterone, Ketoconazol, and Flutamide in treatment.

StudyMed

April 27, 2024

602 views

Hormone Therapy Options for Prostate Cancer Treatment

Hormone Therapy Options for Prostate Cancer Treatment

This 8-minute video provides insights on prostate cancer care focusing on hormone therapy, including the use of LHRH agonists like Goserelin and Leuprolide, and antagonists such as Degarelix, explaining their mechanisms and clinical roles in treatment.

StudyMed

April 27, 2024

284 views

  • Satoru Mitsuboshi
    @3stars67664378 (Twitter)

    Gynecomastia https://t.co/5rODLe9Nwr https://t.co/gbVXdVHG1t https://t.co/RllsUsSSLE Review https://t.co/gbVXdVHG1t https://t.co/Ub9vjKEdXj https://t.co/W5JnQf1UiC https://t.co/T2I0c8GLUj https://t.co/RyeI0wSBD9 https://t.co/p5MPGBgPWm https://t.co/d7C4nTQovc
    view full post

    June 9, 2021

Abstract Synopsis

  • Gynecomastia is a common side effect in up to 70% of prostate cancer patients treated with antiandrogens like bicalutamide, impacting their quality of life.
  • The review analyzed 11 studies, mainly involving pharmacological treatments such as tamoxifen and anastrozole, as well as radiotherapy, finding that both are effective options with manageable side effects.
  • Overall, tamoxifen (10-20 mg daily) and radiotherapy are recommended for managing bicalutamide-induced gynecomastia, with tamoxifen being particularly effective for both prevention and treatment.]